Identification of Metabolic Alterations in Breast Cancer Using Mass Spectrometry-Based Metabolomic Analysis

Area of Science:

• Oncology
• Metabolomics
• Biochemistry

Background:

• Breast cancer (BC) is a significant global health concern and a leading cause of cancer-related mortality in women.
• Despite advancements in molecular diagnostics, earlier detection of BC remains crucial for improving survival rates.
• Altered cellular metabolism is a known hallmark of cancer, suggesting potential for metabolic profiling in BC diagnosis.

Purpose of the Study:

• To investigate and compare the metabolic differences between breast cancer tissues and healthy control tissues.
• To identify potential breast cancer biomarkers through the analysis of differential metabolite expression.
• To explore the metabolic networks and pathways associated with breast cancer.

Main Methods:

• Utilized two analytical mass spectrometry (MS) platforms: hydrophilic interaction chromatography (HILIC) and gas chromatography (GC).
• Generated comprehensive metabolic profiles from breast tissue samples of BC patients and healthy controls.
• Employed bioinformatics tools including Chemical Similarity Enrichment Analysis (ChemRICH), MetaMapp, and Metabolite Set Enrichment Analysis (MSEA) for data analysis.

Main Results:

• Identified differentially expressed metabolites specific to breast cancer tissues.
• Revealed significantly enriched metabolic clusters and networks in BC tissues through advanced analytical methods.
• Established distinct metabolic signatures differentiating BC from healthy tissues.

Conclusions:

• Metabolomic profiling offers a promising avenue for identifying novel biomarkers for earlier breast cancer detection.
• The identified metabolic alterations in BC tissues warrant further investigation and validation for clinical application.
• Further research focusing on validating these metabolomic signatures could significantly advance BC diagnostics and patient outcomes.